ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$RARE:NASDAQ · ULTRAGENYX PHARMACEUTICAL IN

Sector: health

Conviction from: NASDAQ

52-week range: 12.7339.89

Ultragenyx Pharmaceutical develops and commercializes treatments for rare and ultra-rare genetic diseases, including metabolic, bone, and gene-therapy programs.

3 tracked filer(s) hold this · 3 opened, 0 added, 0 trimmed in 30-SEP-2026

Aggregate 13FScore 64 — mean of 3 scored holder(s) · buyers (new/add) avg 64. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61New buy12,600$189,3780.0%
Steve Cohen / Point7275New buy844,410$12,691,4820.0%
Bridgewater55New buy57,052$857,4920.0%

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

3 disclosed trade(s) by 1 filer(s).

Trade dateWhoTypeAmount
2026-09-29Gilbert Cisneros CA31BUY$1,001 - $15,000PTR
2026-03-03Gilbert Cisneros CA31BUY$1,001 - $15,000PTR
2026-02-18Gilbert Cisneros CA31BUY$1,001 - $15,000PTR

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.